Terms: = Uterine cancer AND HRAS, K-ras, 3265, ENSG00000174775, HRAS1, RASH1, c-bas/has, P01112, N-ras AND Diagnosis
25 results:
1. Clinicopathological and Molecular Differences Between Gastric-type Mucinous Carcinoma and Usual-type Endocervical Adenocarcinoma of the uterine Cervix.
Jung H; Bae GE; Kim HM; Kim HS
Cancer Genomics Proteomics; 2020; 17(5):627-641. PubMed ID: 32859641
[TBL] [Abstract] [Full Text] [Related]
2. Preoperative clinical characteristics scoring system for differentiating uterine leiomyosarcoma from fibroid.
Zhang G; Yu X; Zhu L; Fan Q; Shi H; Lang J
BMC Cancer; 2020 Jun; 20(1):514. PubMed ID: 32493236
[TBL] [Abstract] [Full Text] [Related]
3. Ovarian mucinous tumors with mural nodules: immunohistochemical and molecular analysis of 3 cases.
Shao Y; Liu Q; Shi H; Lu B
Diagn Pathol; 2020 Apr; 15(1):35. PubMed ID: 32290854
[TBL] [Abstract] [Full Text] [Related]
4. Gene Promoter Methylation in Endometrial Carcinogenesis.
Cornel KMC; Wouters K; Van de Vijver KK; van der Wurff AAM; van Engeland M; Kruitwagen RFPM; Pijnenborg JMA
Pathol Oncol Res; 2019 Apr; 25(2):659-667. PubMed ID: 30430425
[TBL] [Abstract] [Full Text] [Related]
5. Müllerian Adenosarcoma of the Urinary Bladder: Clinicopathologic and Immunohistochemical Features With Novel Genetic Aberrations.
Sanfrancesco J; Williamson SR; Kum JB; Zhang S; Wang M; Lopez-Beltran A; Montironi R; Gardner TA; Cheng L
Clin Genitourin Cancer; 2017 Dec; 15(6):e1007-e1014. PubMed ID: 28690098
[TBL] [Abstract] [Full Text] [Related]
6. Surgical treatment of high stage endometrial cancer: current perspectives.
Vitale SG; Valenti G; Gulino FA; Cignini P; Biondi A
Updates Surg; 2016 Jun; 68(2):149-54. PubMed ID: 26826083
[TBL] [Abstract] [Full Text] [Related]
7. Low-grade epithelial ovarian cancer: a number of distinct clinical entities?
Oswald AJ; Gourley C
Curr Opin Oncol; 2015 Sep; 27(5):412-9. PubMed ID: 26241347
[TBL] [Abstract] [Full Text] [Related]
8. Carcinogenic mechanisms of endometrial cancer: involvement of genetics and epigenetics.
Banno K; Yanokura M; Iida M; Masuda K; Aoki D
J Obstet Gynaecol Res; 2014 Aug; 40(8):1957-67. PubMed ID: 25131761
[TBL] [Abstract] [Full Text] [Related]
9. Genome-wide single nucleotide polymorphism arrays as a diagnostic tool in patients with synchronous endometrial and ovarian cancer.
Ikeda Y; Oda K; Nakagawa S; Murayama-Hosokawa S; Yamamoto S; Ishikawa S; Wang L; Takazawa Y; Maeda D; Wada-Hiraike O; Kawana K; Fukayama M; Aburatani H; Yano T; Kozuma S; Taketani Y
Int J Gynecol Cancer; 2012 Jun; 22(5):725-31. PubMed ID: 22635024
[TBL] [Abstract] [Full Text] [Related]
10. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?
Alvarez T; Miller E; Duska L; Oliva E
Am J Surg Pathol; 2012 May; 36(5):753-61. PubMed ID: 22498825
[TBL] [Abstract] [Full Text] [Related]
11. Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.
McCluggage WG
Pathology; 2011 Aug; 43(5):420-32. PubMed ID: 21716157
[TBL] [Abstract] [Full Text] [Related]
12. Endometrioid carcinoma of the endometrium: pathologic and molecular features.
Azueta A; Gatius S; Matias-Guiu X
Semin Diagn Pathol; 2010 Nov; 27(4):226-40. PubMed ID: 21309258
[TBL] [Abstract] [Full Text] [Related]
13. A 14-year-old female patient with FIGO stage IB endometrial carcinoma: a case report.
Mitamura T; Watari H; Todo Y; Koshida T; Sakuragi N
Int J Gynecol Cancer; 2009 Jul; 19(5):896-7. PubMed ID: 19574781
[TBL] [Abstract] [Full Text] [Related]
14. Molecular pathology of endometrial carcinoma: practical aspects from the diagnostic and therapeutic viewpoints.
Llobet D; Pallares J; Yeramian A; Santacana M; Eritja N; Velasco A; Dolcet X; Matias-Guiu X
J Clin Pathol; 2009 Sep; 62(9):777-85. PubMed ID: 18977806
[TBL] [Abstract] [Full Text] [Related]
15. [The premalignant disease of the endometrium: endometrial intraepithelial neoplasia].
Francz M
Magy Onkol; 2008 Mar; 52(1):35-40. PubMed ID: 18403295
[TBL] [Abstract] [Full Text] [Related]
16. [Tumor markers useful in the diagnostics and monitoring of endometrial and cervical cancer].
Bedkowska GE; Lawicki S; Szmitkowski M
Postepy Hig Med Dosw (Online); 2007; 61():122-8. PubMed ID: 17369780
[TBL] [Abstract] [Full Text] [Related]
17. [diagnosis of papilloma viruses in cervical cancer in 414 women from Wielkopolska region by the immunohistochemical assessment].
Kedzia W; Schmidt M; Poreba E; Goździcka-Józefiak A; Kedzia H; Spaczyński M
Ginekol Pol; 2005 Jul; 76(7):548-54. PubMed ID: 16363381
[TBL] [Abstract] [Full Text] [Related]
18. Acute myelogenous leukemia relapsing as granulocytic sarcoma of the cervix. A case report.
Delaflor-Weiss E; Zauber NP; Kintiroglou M; Berman EL; DeWitt R; Malczynski D
Acta Cytol; 1999; 43(6):1124-30. PubMed ID: 10578990
[TBL] [Abstract] [Full Text] [Related]
19. Role of tumour markers, cytogenetics.
Lamerz R
Ann Oncol; 1999; 10 Suppl 4():145-9. PubMed ID: 10436809
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic value of p53 and k-ras-2 topographic genotyping in endometrial carcinoma: a clinicopathologic and molecular comparison.
Jones MW; Kounelis S; Hsu C; Papadaki H; Bakker A; Swalsky PA; Finkelstein SD
Int J Gynecol Pathol; 1997 Oct; 16(4):354-60. PubMed ID: 9421075
[TBL] [Abstract] [Full Text] [Related]
[Next]